• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TVA MEDICAL, INC. WAVELINQ ENDOAVF SYSTEM; ENDOVASCULAR ARTERIOVENOUS FISTULA DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TVA MEDICAL, INC. WAVELINQ ENDOAVF SYSTEM; ENDOVASCULAR ARTERIOVENOUS FISTULA DEVICE Back to Search Results
Model Number FX-001CE
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Code Aneurysm (1708)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
As the lot number for the device was not provided, a manufacturing review could not be performed.The sample was not returned to the manufacturer for inspection/evaluation.Therefore, the investigation of the reported event is inconclusive.Based upon the available information, the definitive root cause for this event is unknown.The instructions for use (ifu) is adequate for the reported device/patient code(s) and provides general instructions for use, as well as warnings, precautions and potential complications associated with the device.Upon receipt of new or additional information, a follow-up report will be submitted as applicable.
 
Event or Problem Description
It was reported that approximately five weeks post successful fistula creation, the patient developed an alleged aneurysm between the ulnar artery and ulnar vein requiring the patient to go into surgery for a bypass procedure.It was further alleged that there was some extravasation and spasms after the successful fistula creation procedure but, no treatment was provided.Reportedly, the patient is doing well post bypass surgery procedure.
 
Event or Problem Description
It was reported that approximately five weeks post successful fistula creation, the patient developed an alleged aneurysm between the ulnar artery and ulnar vein requiring the patient to go into surgery for a bypass procedure.It was further alleged that there was some extravasation and spasms after the successful fistula creation procedure but, no treatment was provided.Reportedly, the patient is doing well post bypass surgery procedure.
 
Additional Manufacturer Narrative
Manufacturing review: a review of manufacturing records could not be completed as the device lot number is unknown.A dhr review could not be performed as the lot number is unknown.This is the first complaint reported for this lot number to date.Investigation summary: an image review was performed.The fistula formation catheters are next to each other proximally and in appropriate position at the level of the electrode.Distally the arterial and venous catheters are close, but there remains approximately two catheters width between the magnets at the distal most magnets and key findings that the catheters appear to be in acceptable position for fistula formation.The investigation is inconclusive due to the fact that no sample was returned for evaluation.The root cause could not be determined based upon available information.It is unknown whether patient and/or procedural factors contributed to the event.Labeling review: the review of the ifu (instructions for use), indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WAVELINQ ENDOAVF SYSTEM
Common Device Name
ENDOVASCULAR ARTERIOVENOUS FISTULA DEVICE
Manufacturer (Section D)
TVA MEDICAL, INC.
7000 bee cave road
suite 250
austin TX 78746
MDR Report Key8501970
Report Number3011392541-2019-00004
Device Sequence Number2798598
Product Code PQK
UDI-Device Identifier00868260000211
UDI-Public(01)00868260000211
Combination Product (Y/N)N
Initial Reporter StateAL
Initial Reporter CountryUS
PMA/510(K) Number
DEN160006
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 08/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberFX-001CE
Device Catalogue NumberFX-001CE
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 03/14/2019
Supplement Date Received by Manufacturer08/08/2019
Initial Report FDA Received Date04/10/2019
Supplement Report FDA Received Date08/16/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
-
-